Intervention

dabrafenib

ClinicalTrials.gov intervention label

Clinical trials2
Recruiting1
Common conditions25
Lead sponsors shown1

Common conditions

Anaplastic Astrocytoma1Anaplastic Ganglioglioma1Anaplastic Oligodendroglioma1Anaplastic Pleomorphic Xanthoastrocytoma1Angiocentric Glioma1Astrocytoma1Central Neurocytoma1Cerebellar Liponeurocytoma1Chordoid Glioma of Third Ventricle1Desmoplastic Infantile Astrocytoma and Ganglioglioma1Diffuse Astrocytoma1Dysplastic Gangliocytoma of Cerebrellum1Extraventricular Neurocytoma1Gangliocytoma1Ganglioglioma1Giant Cell Astrocytoma1Glioblastoma1High Grade Glioma1Melanoma1Neurofibromatosis Type 11Non Small Cell Lung Cancer1Oligodendroglioma, Childhood1Papillary Glioneuronal Tumor1Pilocytic Astrocytoma1Pleomorphic Xanthoastrocytoma1

Trial status mix

ACTIVE_NOT_RECRUITING1
RECRUITING1

Phase mix

PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.